Gut Microbiota in Movement Disorders

The gut microbiota has been implicated in neurodevelopment, neuroinflammatory responses, and neurological disorders. Here is the latest research on the role of the gut microbiota in movement disorders.

August 23, 2020
Open Access

Acupuncture inhibits neuroinflammation and gut microbial dysbiosis in a mouse model of Parkinson's disease

Brain, Behavior, and Immunity
Jae-Hwan JangHi-Joon Park
October 19, 2020

A review on preventive role of ketogenic diet (KD) in CNS disorders from the gut microbiota perspective

Reviews in the Neurosciences
Kajal RawatLekha Saha
January 6, 2021
Comment / Editorial
Open Access

Comment on "Microbiota Composition and Metabolism Are Associated With Gut Function in Parkinson's Disease"

Movement Disorders : Official Journal of the Movement Disorder Society
Xi Zhang
January 8, 2021
Open Access

Gut Microbiota Dysbiosis Is Associated with Elevated Bile Acids in Parkinson's Disease

Metabolites
Peipei LiViviane Labrie
August 28, 2020

Gut metagenomics-derived genes as potential biomarkers of Parkinson's disease

Brain : a Journal of Neurology
Yiwei QianQin Xiao
December 31, 2020
Review
Open Access

Niacin and Butyrate: Nutraceuticals Targeting Dysbiosis and Intestinal Permeability in Parkinson's Disease

Nutrients
Tennekoon B KarunaratneAmol Sharma
October 14, 2020
Open Access

Using data science for medical decision making case: role of gut microbiome in multiple sclerosis

BMC Medical Informatics and Decision Making
Jasminka Hasic Telalovic, Azra Music
November 10, 2020

The Gut Mycobiome in Parkinson's Disease

Journal of Parkinson's Disease
Mihai S CirsteaSilke Appel-Cresswell
November 30, 2020
Open Access

An integrated metagenomics and metabolomics approach implicates the microbiota-gut-brain axis in the pathogenesis of Huntington's disease

Neurobiology of Disease
Geraldine KongAnthony J Hannan
September 18, 2020

Gut microbiota dynamics in Parkinsonian mice

ACS Chemical Neuroscience
Emily KlannVinata Vedam-Mai
December 24, 2020
Preprint
Open Access

Overexpression of human alpha-synuclein leads to dysregulated microbiome and metabolites with ageing in a rat model of Parkinson disease

BioRxiv : the Preprint Server for Biology
Yogesh SinghNicolas Casadei
January 11, 2021
Open Access

The impact of dextran sodium sulphate and probiotic pre-treatment in a murine model of Parkinson's disease

Journal of Neuroinflammation
Zach DwyerShawn Hayley
November 10, 2020
Review

Dysbiosis is one of the risk factor for stroke and cognitive impairment and potential target for treatment

Pharmacological Research : the Official Journal of the Italian Pharmacological Society
Magdalena KoszewiczzGjumrakch Aliev
October 2, 2020
Open Access

DJ-1 (Park7) affects the gut microbiome, metabolites and the development of innate lymphoid cells (ILCs)

Scientific Reports
Yogesh SinghOlaf Riess
October 2, 2020

A single bacterial genus maintains root growth in a complex microbiome

Nature
Omri M FinkelJeffery L Dangl
December 5, 2020
Open Access

Gut microbial ecosystem in Parkinson's disease: New clinico-biological insights from multi-omics

Annals of Neurology
Ai Huey TanAnthony E Lang
October 22, 2020

The impact of intestinal microbiota on weight loss in Parkinson's disease patients: a pilot study

Future Microbiology
Federica Del ChiericoFabrizio Stocchi
October 21, 2020
Open Access

Gut bacterial deamination of residual levodopa medication for Parkinson's disease

BMC Biology
Sebastiaan P van KesselSahar El Aidy
December 29, 2020
Comment / Editorial
Open Access

Editorial: Role of Diet, Physical Activity and Immune System in Parkinson's Disease

Frontiers in Neurology
Giovanni AlbaniAli Keshavarzian

Sign up to follow this feed and discover related papers.

Related Feeds

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Alpha-Synuclein Structure & Function

α-Synuclein is an integral component of Lewy bodies which are comprised of protein clumps and are a pathological hallmark of Parkinson’s disease. Here is the latest research on α-synuclein structure and function.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antisense Oligonucleotide Therapies: ND

Antisense oligonucleotides are synthetic DNA oligomers that hybridize to a target RNA. This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases.

Astrocytes & Huntington’s Disease

Astrocytes are abundant within the central nervous system and their dysfunction has been thought to be an important contributor to some neurodegenerative diseases, in particular Huntington’s disease. Damage to these cells may make neurons more susceptible to degeneration. Here is the latest research on astrocytes and Huntington’s disease.

Astrocytes & Neurodegeneration

Astrocytes are important for the health and function of the central nervous system. When these cells stop functioning properly, either through gain of function or loss of homeostatic controls, neurodegenerative diseases can occur. Here is the latest research on astrocytes and neurodegeneration.

© 2021 Meta ULC. All rights reserved
/feed-previews/gut-microbiota-in-movement-disorders/7ce8573c-14ce-4c0b-b390-6f3f6d30a962